135 related articles for article (PubMed ID: 37920153)
1. Tracking tumor evolution during the first-line treatment in brain glioma
Sheng Z; Bu C; Mei J; Xu S; Zhang Z; Guo G; Gao Y; Xing L; Chen Z; Hernesniemi J; Zemmar A; Bu X
Front Oncol; 2023; 13():1238607. PubMed ID: 37920153
[TBL] [Abstract][Full Text] [Related]
2. Characterizing the Genomic Landscape of Brain Glioma With Circulating Tumor DNA From Tumor
Sheng Z; Yu J; Deng K; Andrade-Barazarte H; Zemmar A; Li S; Li N; Yan Z; Chen Z; Sun Y; Hernesniemi J; Bu X
Front Oncol; 2021; 11():584988. PubMed ID: 33868989
[TBL] [Abstract][Full Text] [Related]
3. Cell-Free Tumor DNA (cf-tDNA) Liquid Biopsy: Current Methods and Use in Brain Tumor Immunotherapy.
Wadden J; Ravi K; John V; Babila CM; Koschmann C
Front Immunol; 2022; 13():882452. PubMed ID: 35464472
[TBL] [Abstract][Full Text] [Related]
4. Electronic DNA Analysis of CSF Cell-free Tumor DNA to Quantify Multi-gene Molecular Response in Pediatric High-grade Glioma.
Bruzek AK; Ravi K; Muruganand A; Wadden J; Babila CM; Cantor E; Tunkle L; Wierzbicki K; Stallard S; Dickson RP; Wolfe I; Mody R; Schwartz J; Franson A; Robertson PL; Muraszko KM; Maher CO; Garton HJL; Qin T; Koschmann C
Clin Cancer Res; 2020 Dec; 26(23):6266-6276. PubMed ID: 33087334
[TBL] [Abstract][Full Text] [Related]
5. Serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline glioma.
Cantor E; Wierzbicki K; Tarapore RS; Ravi K; Thomas C; Cartaxo R; Nand Yadav V; Ravindran R; Bruzek AK; Wadden J; John V; May Babila C; Cummings JR; Rahman Kawakibi A; Ji S; Ramos J; Paul A; Walling D; Leonard M; Robertson P; Franson A; Mody R; Garton HJL; Venneti S; Odia Y; Kline C; Vitanza NA; Khatua S; Mueller S; Allen JE; Gardner SL; Koschmann C
Neuro Oncol; 2022 Aug; 24(8):1366-1374. PubMed ID: 35137228
[TBL] [Abstract][Full Text] [Related]
6. Tumor DNA From Tumor
Yu J; Sheng Z; Wu S; Gao Y; Yan Z; Bu C; Gu J; Bu Y; Deng K; Xu S; Chen Z; Zhang Q; Zemmar A; Hernesniemi J; Wang M; Liu G; Li T; Bu X
Front Oncol; 2021; 11():742037. PubMed ID: 34712610
[TBL] [Abstract][Full Text] [Related]
7. The Prognostic and Therapeutic Value of the Mutational Profile of Blood and Tumor Tissue in Head and Neck Squamous Cell Carcinoma.
Wilson HL; D'Agostino RB; Meegalla N; Petro R; Commander S; Topaloglu U; Zhang W; Porosnicu M
Oncologist; 2021 Feb; 26(2):e279-e289. PubMed ID: 33098199
[TBL] [Abstract][Full Text] [Related]
8. Utility of Serial cfDNA NGS for Prospective Genomic Analysis of Patients on a Phase I Basket Study.
Smyth LM; Reichel JB; Tang J; Patel JAA; Meng F; Selcuklu DS; Houck-Loomis B; You D; Samoila A; Schiavon G; Li BT; Razavi P; Piscuoglio S; Reis-Filho JS; Taylor BS; Baselga J; Solit DB; Hyman DM; Berger MF; Chandarlapaty S
JCO Precis Oncol; 2021; 5():. PubMed ID: 34250397
[TBL] [Abstract][Full Text] [Related]
9. Genomic Alteration Spectrum of Non-Small Cell Lung Cancer Patients in East-China Characterized by Tumor Tissue DNA and Cell-Free DNA.
Li J; Chen S; Xue H; Wang H; Huang T; Xie H; He J; Ke C; Yu Z; Ni B
Onco Targets Ther; 2022; 15():571-584. PubMed ID: 35615557
[TBL] [Abstract][Full Text] [Related]
10. Prospective blinded study of somatic mutation detection in cell-free DNA utilizing a targeted 54-gene next generation sequencing panel in metastatic solid tumor patients.
Kim ST; Lee WS; Lanman RB; Mortimer S; Zill OA; Kim KM; Jang KT; Kim SH; Park SH; Park JO; Park YS; Lim HY; Eltoukhy H; Kang WK; Lee WY; Kim HC; Park K; Lee J; Talasaz A
Oncotarget; 2015 Nov; 6(37):40360-9. PubMed ID: 26452027
[TBL] [Abstract][Full Text] [Related]
11. Liquid biopsy for pediatric diffuse midline glioma: a review of circulating tumor DNA and cerebrospinal fluid tumor DNA.
Azad TD; Jin MC; Bernhardt LJ; Bettegowda C
Neurosurg Focus; 2020 Jan; 48(1):E9. PubMed ID: 31896079
[TBL] [Abstract][Full Text] [Related]
12.
Juratli TA; Stasik S; Zolal A; Schuster C; Richter S; Daubner D; Juratli MA; Thowe R; Hennig S; Makina M; Meinhardt M; Lautenschlaeger T; Schackert G; Krex D; Thiede C
Clin Cancer Res; 2018 Nov; 24(21):5282-5291. PubMed ID: 29941484
[No Abstract] [Full Text] [Related]
13. Development and clinical validation of a circulating tumor DNA test for the identification of clinically actionable mutations in nonsmall cell lung cancer.
Liu L; Liu H; Shao D; Liu Z; Wang J; Deng Q; Tang H; Yang H; Zhang Y; Qiu Y; Cui F; Tan M; Zhang P; Li Z; Liu J; Liang W; Wang Y; Peng Z; Wang J; Yang H; Mao M; Kristiansen K; Ye M; He J
Genes Chromosomes Cancer; 2018 Apr; 57(4):211-220. PubMed ID: 29277949
[TBL] [Abstract][Full Text] [Related]
14. Up-front mutation detection in circulating tumor DNA by droplet digital PCR has added diagnostic value in lung cancer.
Visser E; de Kock R; Genet S; Borne BVD; Soud MY; Belderbos H; Stege G; de Saegher M; 't Westeinde SV; Broeren M; Eduati F; Deiman B; Scharnhorst V
Transl Oncol; 2023 Jan; 27():101589. PubMed ID: 36413862
[TBL] [Abstract][Full Text] [Related]
15. [Consistency Analysis of Gene Mutation Sites of Bone Marrow Tumor DNA and Circulating Tumor DNA in Patients with Myelodysplastic Syndrome].
Zhao P; Zhu QZ; Fan T; Liu WY; Xiao HY; Qin JY; Huang G; Hu XM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Feb; 27(1):149-158. PubMed ID: 30738462
[TBL] [Abstract][Full Text] [Related]
16. Urinary Molecular Pathology for Patients with Newly Diagnosed Urothelial Bladder Cancer.
Zhang R; Zang J; Xie F; Zhang Y; Wang Y; Jing Y; Zhang Y; Chen Z; Shahatiaili A; Cai MC; Zhao Z; Du P; Jia S; Zhuang G; Chen H
J Urol; 2021 Oct; 206(4):873-884. PubMed ID: 34061567
[TBL] [Abstract][Full Text] [Related]
17. Molecular and clonal evolution
Liu G; Bu C; Guo G; Zhang Z; Sheng Z; Deng K; Wu S; Xu S; Bu Y; Gao Y; Wang M; Liu G; Kong L; Li T; Li M; Bu X
iScience; 2023 Sep; 26(9):107528. PubMed ID: 37649695
[TBL] [Abstract][Full Text] [Related]
18. Examination of Plasma Cell-Free DNA of Glioma Patients by Whole Exome Sequencing.
Sun J; Zhou W; Mao K; He Y; Yao J; Tang Z; Song M; Liu Q; Zhu H; Ju S; Shi J; Shi W
World Neurosurg; 2019 May; 125():e424-e428. PubMed ID: 30703591
[TBL] [Abstract][Full Text] [Related]
19. Improvements in Quality Control and Library Preparation for Targeted Sequencing Allowed Detection of Potentially Pathogenic Alterations in Circulating Cell-Free DNA Derived from Plasma of Brain Tumor Patients.
Szadkowska P; Roura AJ; Wojtas B; Wojnicki K; Licholai S; Waller T; Gubala T; Zukowski K; Karpeta M; Wilkus K; Kaspera W; Nawrocki S; Kaminska B
Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36010895
[TBL] [Abstract][Full Text] [Related]
20. Detection of tumor-derived DNA in cerebrospinal fluid of patients with primary tumors of the brain and spinal cord.
Wang Y; Springer S; Zhang M; McMahon KW; Kinde I; Dobbyn L; Ptak J; Brem H; Chaichana K; Gallia GL; Gokaslan ZL; Groves ML; Jallo GI; Lim M; Olivi A; Quinones-Hinojosa A; Rigamonti D; Riggins GJ; Sciubba DM; Weingart JD; Wolinsky JP; Ye X; Oba-Shinjo SM; Marie SK; Holdhoff M; Agrawal N; Diaz LA; Papadopoulos N; Kinzler KW; Vogelstein B; Bettegowda C
Proc Natl Acad Sci U S A; 2015 Aug; 112(31):9704-9. PubMed ID: 26195750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
